Abstract
We evaluated long-term survival analysisand quality of life over 10 years after heart valve replacement with a St. Jude Medical prosthetic valve in 44 patients (7 underwent aortic valve replacement, 31 underwent mitral valve replacement, 5 underwent double velve replacement, and 1 underwent Bentall operation). Two died of valve related factor. Actuarial survival rate of total, AVR and MVR were 87.3%. 83% and 93.1%. respectively. Thromboembolism free rate, re-operation free rate, and prosthetic valve endocarditis free rate were 92.4%, 90.0%, 97.6%, respectively. Valve related event free rate was 89.7%. In conclusion, this study demonstrated that the SJM valve showed a low incidence of event over 10 years after operation. These results endorse our choice of the SJM valve.
